Inventor · disambiguated record
Sean A. Beausoleil
Also filed as: BEAUSOLEIL SEAN · BEAUSOLEIL SEAN A · BEAUSOLEIL SEAN ANDRE
6 granted patents·5 pending applications·2 citations·filing 2007–2025
70Inventor score
Files withBLUEFIN BIOMEDICINE INC6CELL SIGNALING TECHNOLOGY INC2GYGI STEVEN P1HORNBECK PETER1POLAKIEWICZ ROBERTO1
Top patents by PatentIndex Score
11 records- 0182US11434303B2Anti-LY6H antibodies and antibody drug conjugatesBLUEFIN BIOMEDICINE INC·Filed 2018·Granted Sep 6, 2022·1 cites·12 claims
- 0277US2025368747A1Anti-il1rap antibodies and compositionsBLUEFIN BIOMEDICINE INC·Filed 2025·Application pending·0 cites
- 0376US12296006B2Anti-LY6H antibodies and antibody drug conjugatesBLUEFIN BIOMEDICINE INC·Filed 2022·Granted May 13, 2025·0 cites·14 claims
- 0473US2025319180A1Anti-ly6h antibodies and antibody drug conjugatesBLUEFIN BIOMEDICINE INC·Filed 2025·Application pending·0 cites
- 0569US12350347B2Nucleic acids encoding anti-IL1RAP antibodies and their usesBLUEFIN BIOMEDICINE INC·Filed 2021·Granted Jul 8, 2025·0 cites·13 claims
- 0666US8618248B2Phosphopeptide compositions and anti-phosphopeptide antibody compositions and methods of detecting phosphorylated peptidesGYGI STEVEN P·Filed 2007·Granted Dec 31, 2013·1 cites·19 claims
- 0759US11248054B2Anti-IL1RAP antibodies and antibody drug conjugatesBLUEFIN BIOMEDICINE INC·Filed 2018·Granted Feb 15, 2022·0 cites·8 claims
- 0849US2019002532A1Methods and reagents for creating monoclonal antibodiesCELL SIGNALING TECHNOLOGY INC·Filed 2018·Application pending·0 cites
- 0943US2015110794A1Anti-Human Cytomegalovirus Antibodies And Use ThereofCELL SIGNALING TECHNOLOGY INC·Filed 2013·Application pending·0 cites
- 1042US9920110B2Methods and reagents for creating monoclonal antibodiesPOLAKIEWICZ ROBERTO·Filed 2012·Granted Mar 20, 2018·0 cites·32 claims
- 1137US2014336360A1Tyrosine, Serine and Threonine Phosphorylation SitesHORNBECK PETER·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sean A. Beausoleil files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →